DCPH
Deciphera Pharmaceuticals LLC
NASDAQ: DCPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$25.59
+0.00% today
Updated 2026-04-30
Market cap
$2.21B
P/E ratio
—
P/S ratio
12.65x
EPS (TTM)
$-2.21
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
Deciphera Pharmaceuticals LLC (DCPH) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+6.3%
Last 4 quarters
Revenue YoY growth
+34.5%
Most recent quarter
EPS YoY growth
+13.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.5%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-5.0%
2024-02-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2024-06-20 | $-0.52 | +5.5% | $25.59 | $25.59 | +0.0% |
| 2024-02-06 | $-0.54 | +6.9% | $14.76 | $14.02 | -5.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2024-03-31 | $-0.55 | $-0.52 | +5.5% | $45.00M | +34.5% |
| 2023-12-31 | $-0.58 | $-0.54 | +6.9% | $48.29M | +32.9% |
| 2023-09-30 | $-0.61 | $-0.58 | +4.9% | $43.31M | +20.4% |
| 2023-06-30 | $-0.62 | $-0.57 | +8.1% | $38.30M | +17.9% |
| 2023-03-31 | $-0.59 | $-0.60 | -1.7% | $33.45M | +14.4% |
| 2022-12-31 | $-0.56 | $-0.60 | -7.1% | $36.34M | +50.2% |
| 2022-09-30 | $-0.58 | $-0.55 | +5.2% | $35.97M | +54.9% |
| 2022-06-30 | $-0.66 | $-0.60 | +9.1% | $32.49M | +37.8% |
| 2022-03-31 | $-0.90 | $-0.80 | +11.1% | $29.22M | — |
| 2021-12-31 | $-1.38 | $-1.51 | -9.4% | $24.20M | — |
| 2021-09-30 | $-1.28 | $-1.37 | -7.0% | $23.22M | — |
| 2021-06-30 | $-1.15 | $-1.21 | -5.2% | $23.57M | — |
Frequently asked questions
Has Deciphera Pharmaceuticals LLC beaten earnings estimates?
Deciphera Pharmaceuticals LLC has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +6.3% over the last 4 quarters.
How does DCPH stock react to earnings?
DCPH stock has moved an average of -2.5% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Deciphera Pharmaceuticals LLC's revenue growth rate?
Deciphera Pharmaceuticals LLC reported year-over-year revenue growth of +34.5% in its most recent quarter, with EPS growing +13.3% year-over-year.